References
- 1. SIMONNEAU G, GATZOULIS MA, ADATIA I, CELERMAJER D, DENTON C, GHOFRANI A, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2013;62:D34–41.
- 2. The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Guidelines for the diagnosis and treatment of pulmonary hypertension. European Heart Journal 2009; 30:2493–2537.
- 3. MONTANI D, PRICE LC, DORFMULLER P, ACHOUH L, JAÏS X, YAÏCI A, et al. Pulmonary veno-occlusive disease. Eur Respir J 2009; 33: 189–200.
- 4. MORASSUT PA, WALLEY VM, SMITH CD. Pulmonary veno-occlusive disease and the CREST variant of scleroderma. Can J Cardiol. 1992;8(10):1055-1058.
- 5. ZHANG L, VISSCHER D, RIHAL C, AUBRY MC. Pulmonary veno-occlusive disease as a primary cause of pulmonary hypertension in a patient with mixed connective tissue disease. Rheumatol Int 2007; 27: 1163–1165.
- 6. HOURSEAU M, CAPRON F, NUNES H, GODMER P, MARTIN A, KAMBOUCHNER M. Pulmonary veno-occlusive disease in a patient with HIV infection. A case report with autopsy findings. Ann Pathol. 2002;22(6):472-475.
- 7. WILLIAMS LM, FUSSELL S, VEITH RW, NELSON S, MASON CM. Pulmonary veno-occlusive disease in an adult following bone marrow transplantation. Case report and review of the literature. Chest 1996; 109: 1388–1391.
- 8. SEGUCHI M, HIRABAYASHI N, FUJII Y, et al. Pulmonary hypertension associated with pulmonary occlusive vasculopathy after allogeneic bone marrow transplantation. Transplantation 2000; 69: 177–179.
- 9. NUNES H, HUMBERT M, CAPRON F, et al. Pulmonary hypertension associated with sarcoidosis: mechanisms, hemodynamics and prognosis. Thorax 2006; 61: 68–74. 31
- 10. FARTOUKH M, HUMBERT M, CAPRON F, et al. Severe pulmonary hypertension in histiocytosis X. Am J Respir Crit Care Med 2000; 161: 216–223.
- 11. KHANNA D. Diagnosis and treatment of systemic and localized scleroderma. Expert Rev. Dermatol. 2011; 6(3):287–302.
- 12. CHAISSON NF, HASSOUN PM. Systemic Sclerosis-Associated Pulmonary Arterial Hypertension. CHEST 2013; 144(4): 1346–1356.
- 13. LAMBOVA S. Cardiac manifestations in systemic sclerosis. World J Cardiol 2014 26; 6(9): 993-1005.
- 14. KHANNA D, GLADUE H, CHANNICK R, CHUNG L, DISTLER O, FURST DE, et al. Recommendations for Screening and Detection of Connective-Tissue Disease Associated Pulmonary Arterial Hypertension. Arthritis Rheum. 2013; 65(12): 3194-201.
- 15. MONTANI D, O’CALLAGHAN DS, SAVALE L, JAÏS X, YAÏCI A, MAITRE S, et al. Pulmonary veno-occlusive disease: Recent progress and current challenges. Respiratory Medicine. 2010; 104:S23eS32.
- 16. HORA J. Zur Histologie der klinischen “primaren Pulmonalsklerose”. Frankfurt Z Pathol. 1934; 47:100-08.
- 17. RUNO JR, VNENCAK-JONES CL, PRINCE M, et al. Pulmonary venoocclusive disease caused by an inherited mutation in bone morphogenetic protein receptor II. Am J Respir Crit Care Med 2003; 167(6):889e94.
- 18. GAGNADOUX F, CAPRON F, LEBEAU B. Pulmonary veno-occlusive disease after neoadjuvant mitomycin chemotherapy and surgery for lung carcinoma. Lung Cancer 2002; 36(2):213e5.
- 19. JOSELSON R, WARNOCK M. Pulmonary veno-occlusive disease after chemotherapy. Hum Pathol. 1983; 14(1):88-91.
- 20. LOMBARD CM, CHURG A, WINOKUR S. Pulmonary veno-occlusive disease following therapy for malignant neoplasms. Chest. 1987; 92(5):871-876.
- 21. MONTANI D, ACHOUH L, DORFMULLER P, et al. Pulmonary venoocclusive disease: Clinical, functional, radiologic, hemodynamic characteristics and outcome of 24 cases confirmed by histology. Medicine (Baltimore) 2008; 87: 220–233.
- 22. KRAMER MR, ESTENNE M, BERKMAN N, ANTOINE M, DE FRANCQUEN P, LIPSKI A, et al. Radiation-induced pulmonary veno-occlusive disease. Chest. 1993; 104(4):1282-1284.
- 23. JOHNSON SR, PATSIOS D, HWANG DM, GRANTON JT. Pulmonary veno-occlusive disease and scleroderma associated pulmonary hypertension. J Rheumatol 2006; 33:2347–2350.
- 24. LANTUEJOUL S, SHEPPARD MN, CORRIN B, BURKE MM, NICHOLSON AG. Pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis: a clinicopathologic study of 35 cases. Am J Surg Pathol 2006; 30: 850–857.
- 25. DORFMULLER P, HUMBERT M, PERROS F, et al. Fibrous remodeling of the pulmonary venous system in pulmonary arterial hypertension associated with connective tissue diseases. Hum Pathol 2007; 38: 893–902.
- 26. NICOD P, MOSER KM. Primary pulmonary hypertension. The risk and benefit of lung biopsy. Circulation.1989; 80(5): 1486-1488.
- 27. PALMER SM, ROBINSON LJ, WANG A, GOSSAGE JR, BASHORE T, TAPSON VF. Massive pulmonary oedema and death after prostacyclin infusion in a patient with pulmonary venoocclusive disease. Chest 1998; 113: 237–240.
- 28. CREAGH-BROWN BC, NICHOLSON AG, SHOWKATHALI R, GIBBS JS, HOWARD LS. Pulmonary veno-occlusive disease presenting with recurrent pulmonary oedema and the use of nitric oxide to predict response to sildenafil. Thorax 2008; 63: 933–934.
- 29. GUPTA R. Pulmonary function test as screening test for pulmonary artery hypertension in scleroderma patients. Rheumatology. 2004; 43(10): 1315.
- 30. RABILLER A, JAIS X, HAMID A, et al. Occult alveolar haemorrhage in pulmonary veno-occlusive disease. Eur Respir J 2006; 27: 108–113.
- 31. GŰNTHER S, JAĎS X, MAITRE S, BÉREZNÉ A, DORFMŰLLER, SEFERIAN A, et al. Computed tomography findings of pulmonary venoocclusive disease in scleroderma patients presenting with precapillary pulmonary hypertension. Arthritis Rheum. 2012; 64(9):2995–3005.
- 32. MEYER KC, RAGHU G, BAUGHMAN RP, BROWN KK, COSTABEL U, DU BOIS RM, et al. An official american thoracic society clinical practice guideline: The clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease. Am J Respir Crit Care Med 185(9):1004–1014.
- 33. D. MONTANI, X. JAÏS, P. DORFMULLER, G. SIMONNEAU, O. SITBON, M. HUMBERT. Goal-oriented therapy in pulmonary veno-occlusive disease: a word of caution. ERJ 2009; 34 (5):1204-1206.